Authors
Latest:
Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid PopulationThe cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.
Latest:
Inflammatory Bowel Disease Readmissions Are Associated With Utilization and ComorbidityThirty-day readmissions related to inflammatory bowel disease are common and associated with longer length of stay and a higher likelihood of having an associated comorbid condition compared with index hospitalizations.
Latest:
Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD SymptomsChanging patients from an inhaled corticosteroid (ICS)/long-acting β agonist (LABA) inhaler and long-acting muscarinic agonist (LAMA) inhaler to a LAMA/LABA inhaler and a separate ICS inhaler did not appear to affect patient-reported chronic obstructive pulmonary disease (COPD) symptom scores.
Latest:
Primary Care Physicians' Views of Medicare Part DPrimary care physicians have mixed views of prescription drug coverage under Medicare Part D.
Latest:
The Combined Effect of the Electronic Health Record and Hospitalist Care on Length of StayNo national studies have examined the interaction effect of the electronic health record (EHR) and hospitalist care on length of stay (LOS). Thus, we examine the combined effect of the EHR and hospitalist care on LOS.
Latest:
Open Doors to Primary Care Should Add a “Screen” to Reduce Low-Value CareFor primary care to fulfill its promise of promoting a healthier population and more efficient spending, deliberate efforts to curtail the use of low-value services are warranted.
Latest:
Retail Clinic Versus Office Setting: Do Patients Choose Appropriate Providers?Care episodes treated in retail clinics appeared to be less complex than those treated in office settings.
Latest:
Automated Telephone Calls to Enhance Colorectal Cancer Screening: Economic AnalysisAutomated telephone calls can increase colorectal cancer screening rates at a cost of about $40 per additional screen.
Latest:
Insurer Costs of COVID-19 by Disease Severity and DurationPayer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.
Latest:
Knowledge Gaps Inhibit Health IT Development for Coordinating Complex Patients' CareThis study examines the leading edge of health information technology used to coordinate the care of complex patients.
Latest:
Comorbidities and Cardiovascular Disease Risk in Older Breast Cancer SurvivorsEffective management of the comorbidities of diabetes and hypertension may increase survival in older breast cancer survivors.
Latest:
A Health Plan's Investigation of Healthy Days and Chronic ConditionsLinking administrative claims to health-related quality of life measured in Healthy Days provides a new vision into the health of populations.
Latest:
Predicting 30-Day Emergency Department Revisits“Frequent flyers” significantly contribute to emergency department (ED) crowding. This study developed a predictive model that can be used to identify high-risk patients and reduce ED revisits.
Latest:
Outcomes Among Chronically Ill Adults in a Medical Home PrototypeThis study investigated healthcare quality, utilization, and costs among patients with common chronic illnesses in a patient-centered medical home prototype redesign.
Latest:
Health Insurance Design and Conservative Therapy for Low Back PainThis study examined the association between health insurance design features and choice of physical therapy or chiropractic care by patients with new-onset low back pain.
Latest:
Assessing Outcomes in Child PsychiatryTwo standardized rating scales appeared to be valid and reliable for use at admission and possibly follow-up in a child psychiatry system of care.
Latest:
Cost-effectiveness of Brentuximab Vedotin With Chemotherapy in Treatment of CD30-Expressing PTCLAn economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).
Latest:
The Role of Behavioral Health Services in Accountable Care OrganizationsData suggest that behavioral health providers and services must be included as core components of accountable care organizations to achieve desired health and cost outcomes.
